Epithelioid sarcoma. Diagnosis, prognostic indicators, and treatment.
D R Chase, F M Enzinger
https://pubmed.ncbi.nlm.nih.gov/4014539/Actively Recruiting
Led by Italian Sarcoma Group · Updated on 2025-11-18
100
Participants Needed
11
Research Sites
73 weeks
Total Duration
Researchers are conducting a prospective observational study to describe the population affected by Epithelioid Sarcoma ES. The study aims to deepen understanding of the diseases natural history, explore differences between classical-type and proximal-type ES variants, and address outstanding questions regarding its management to help tailor treatments and improve patient outcomes. Participants diagnosed with localized or advanced epithelioid sarcoma and treated at Italian reference centers for sarcoma will be observed. Treatments for ES will follow disease guidelines, and the study will track therapies such as radiotherapy and chemotherapy over time. The study does not involve experimental treatments but focuses on collecting detailed information about patient care and disease progression. Throughout the study, researchers will monitor the types of treatments given from diagnosis up to 60 months, including regular assessments of radiotherapy and chemotherapy every six months. They will also study predictive biomarkers for treatment response at diagnosis and during disease progression when biopsies are performed. Participants will provide informed consent and are expected to comply with treatment and follow-up during the study period, which may continue until 2030.
CONDITIONS
An Observational Study on Epithelioid Sarcoma
A
Annamaria Frezza, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Italian Sarcoma Group
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 60 months
Participants with epithelioid sarcoma are observed to understand the natural history of the disease and management outcomes.
Assessments every 6 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
D R Chase, F M Enzinger
https://pubmed.ncbi.nlm.nih.gov/4014539/L Guillou, C Wadden, J M Coindre...
https://pubmed.ncbi.nlm.nih.gov/9042279/A C Halling, P C Wollan, D J Pritchard...
https://pubmed.ncbi.nlm.nih.gov/8656704/G D Bos, D J Pritchard, H M Reiman...
https://pubmed.ncbi.nlm.nih.gov/3392084/Khin Thway, Robin L Jones, Jonathan Noujaim...
https://pubmed.ncbi.nlm.nih.gov/26645461/Italian Sarcoma Group
Lead Sponsor